NCT01625377 A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients Status COMPLETED Phase PHASE3
NCT01624948 Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients Status COMPLETED Phase PHASE4
NCT01624766 Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers Status COMPLETED Phase PHASE1
NCT01608412 A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus Status UNKNOWN Phase PHASE4
NCT01596140 Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01594268 A Prospective, Open Label Study of CERtican in KIdney Transplantation Status COMPLETED Phase PHASE4
NCT01582191 Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT01582009 Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate Status TERMINATED Phase PHASE1/PHASE2
NCT01567488 Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET Status COMPLETED Phase PHASE2
NCT01566279 A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03) Status COMPLETED Phase NA
NCT01563354 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial Status COMPLETED Phase PHASE2
NCT01561404 Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise Status TERMINATED Phase PHASE4
NCT01551212 Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients Status COMPLETED Phase PHASE4
NCT01529554 Controlled Level EVERolimus in Acute Coronary Syndromes Status COMPLETED Phase PHASE1/PHASE2
NCT01525719 Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma Status UNKNOWN Phase PHASE2
NCT01524783 Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) Status COMPLETED Phase PHASE3
NCT01523977 Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL Status COMPLETED Phase PHASE1
NCT01509560 PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood Status COMPLETED Phase PHASE2